Name: Startup Pitch Presentations: Drug Development & Delivery
Start: 2026-09-30T15:15:00+0200
End: 2026-09-30T16:30:00+0200

Startup Pitch Presentations: Drug Development & Delivery

Wednesday September 30, 2026 15:15 - 16:30 CEST

4 Raúl Martín room

Each company will be given a six-minute spotlight to unveil investment opportunities in drug development and delivery—six minutes to ignite interest and sketch the future of medicine.

Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.

Vaxdyn – Juan José Infante Viñolo, CEO
FatrixGel – Pablo Sánchez-Rey Chiapasco, CEO & Founder
Flavii Therapeutics – Ariadna Boloix Amenós & Ainia Bellver , CEO & CSO & Co-founders
Gate2brain – Mertixell Teixidó Turà, CEO & CSO
i+Med S.coop – Andrea Zapater Matute, R&D Business Developer
MIMO BIOSCIENCES – Jessika Valero Gonzalez,. Business Development Director
Nanogrow Biotech – Nicolás Galmarini Galmarini, CEO & Co-founder
Nostrum Biodiscovery –Marie-Eve Beaulieu, General Manager
Olavide Neuron STX S.L. (ONESTX) – Ángel Cebolla Ramírez, CEO
Ploid AI Biotech - Adolfo Gastalver, Co-Founder & CEO
Resistia – Ignacio Massone, CEO & Co-founder
Molefy Pharma - Tania Ortuño, Head of Operations

Speakers

Juan José Infante Viñolo

CEO, Vaxdyn

Dr. Infante leads Vaxdyn and its international collaboration network, advancing vaccines against antibiotic-resistant bacteria. As co-inventor of the company's core technology, he has secured funding from CARB-X, the European Commission and specialist investors. His background combines... Read More →

Pablo Sanchez-rey

CEO & Founder, FatrixGel

Biologist and biotechnologist with a PhD in Biological Sciences and over 10 years of experience in the startup ecosystem. Former COO of a Fermentation Biotech, leading operations, strategic execution, and stakeholder relations. Currently CEO and founder of Fatrix Biotech, a biomaterial... Read More →

Ariadna Boloix Amenós

CEO & Co-founder, Flavii Therapeutics

Dr. Ariadna Boloix Amenós is CEO & Co-founder of Flavii Therapeutics S.L., leading corporate strategy and business development. She holds a PhD in Biochemistry and Biomedicine (UAB) and a Pharmacy degree (UB). Her research at the Vall d’Hebron Research Institute and Institute of Materials Science of Barcel... Read More →

Meritxell Teixidó Turà

Ceo & Cso, Gate2brain

Meritxell Teixidó holds a PhD in Organic Chemistry from the University of Barcelona and an eMBA from UOC. She spent more than 15 years at IRB Barcelona leading research on peptides capable of crossing biological barriers, co-supervising 10 PhDs, publishing over 50 scientific articles... Read More →

Andrea Zapater Matute

R&D Business Developer, i+Med S.coop

Andrea Zapater, PhD, is an R&D Business Development Manager at i+Med, focused on advanced biomaterials and drug delivery technologies for innovative therapeutic applications. She holds a PhD in Personalized Medicine and has experience in biotechnology, translational research, and... Read More →

Jessika Valero Gonzalez

Business Director, Mimo Biosciences

Jessika Valero González, PhD, leads Business Development and Strategy at MIMO Biosciences, where she drives growth, strategic partnerships, and market expansion. With extensive experience in biotechnology innovation and commercialization, she focuses on connecting breakthrough science... Read More →

Nicolás Galmarini

CEO & Co-founder, Nanogrow Biotech

Economist and MBA with over 20 years in the pharmaceutical industry and a proven track record in establishing businesses across Latin America. Holds a BA in Economics from UdelaR and an MBA from Universidad Austral (Argentina). His extensive experience and entrepreneurial mindset... Read More →

Marie-eve Beaulieu

General Manager, Nostrum Biodiscovery

Marie-Eve Beaulieu, PhD is General Manager of Nostrum Biodiscovery, a Barcelona- and Boston-based computational drug discovery technology company developing physics-based AI platforms for therapeutic design. She brings over 15 years of experience spanning drug discovery and executive leadership in biotech. Pr... Read More →

Angel Cebolla Ramírez

CEO, Olavide Neuron STX S.L. (ONESTX)

Dr. Ángel Cebolla is a scientist and serial bioentrepreneur with more than 25 years of experience translating academic research into profitable biotech solutions. After founding Biomedal and leading its world-class rapid food diagnostics division to a successful exit with the US... Read More →

Adolfo Gastalver

Co-Founder & CEO, Ploid AI Biotech

Co-Founder & CEO of Ploid AI. Computer and electrical engineer specialized in AI, with two Master's degrees and a PhD candidacy in electrical engineering. Former AI researcher at CSIC-IIIA, with startup and consulting experience at Ingelectus and BCG.

Tania Ortuño

Head of Operations, Molefy Pharma SL

Tania Ortuño is a biologist and doctor in Neuroscience with extensive experience combining scientific R&D with business development skills in innovation-driven environments. Her career spans neuroscience research and biotech operations, giving her a multidisciplinary profile at the... Read More →

Ignacio Massone

CEO & Co-founder, Resistia

Former Big Pharma leader with a proven track record in business development and product launches. Currently Co-founder and CEO of Resistia, a deep-tech startup developing microbiome-derived therapies that restore the efficacy of existing antibiotics against resistant infections.

... Read More →

Wednesday September 30, 2026 15:15 - 16:30 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

BIOSPAIN 2026